Post-market Reviews of COPD Medicines and Ezetimibe - Extension of public consultation on draft Terms of Reference

Page last updated: 2 November 2015

Consultation on the draft Terms of Reference for the Post-market Reviews of Chronic Obstructive Pulmonary Disease (COPD) Medicines and Ezetimibe has been extended to 13 November 2015.

Interested organisations and individuals are invited to provide comments on the draft Terms of Reference for the Reviews.  For further information please refer to the COPD Review website or Ezetimibe Review website.